Madrigal Pharmaceuticals, Inc.
(NASDAQ : SNTA)

( )
SNTA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading SNTA News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.76%15.618.4%$350.60m
SHPGShire PLC Sponsored ADR
-2.05%172.770.5%$214.39m
MNKMallinckrodt Plc
0.32%53.737.1%$172.09m
PRGOPerrigo Co. Plc
-0.22%84.473.7%$145.91m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.33%120.1911.4%$87.08m
ENDPEndo International Plc
-0.06%15.865.9%$83.30m
UTHRUnited Therapeutics Corporation
5.69%136.7320.3%$75.46m
PRXLPAREXEL International Corporation
4.45%62.625.8%$71.68m
JAZZJazz Pharmaceuticals Plc
2.21%103.872.7%$70.51m
HZNPHorizon Pharma plc
2.75%20.2110.8%$65.42m
MDCOMedicines Company
0.17%34.5416.6%$53.86m
ICPTIntercept Pharmaceuticals, Inc.
2.52%105.8419.0%$51.65m
ICLRICON Plc
0.61%76.374.1%$40.16m
DEPODepomed, Inc.
2.30%19.9819.2%$37.54m
EGRXEagle Pharmaceuticals, Inc.
2.48%79.8327.2%$33.43m

Company Profile

Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.